These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 30763621)

  • 61. Nano based drug delivery systems: recent developments and future prospects.
    Patra JK; Das G; Fraceto LF; Campos EVR; Rodriguez-Torres MDP; Acosta-Torres LS; Diaz-Torres LA; Grillo R; Swamy MK; Sharma S; Habtemariam S; Shin HS
    J Nanobiotechnology; 2018 Sep; 16(1):71. PubMed ID: 30231877
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Silicon nanomaterials platform for bioimaging, biosensing, and cancer therapy.
    Peng F; Su Y; Zhong Y; Fan C; Lee ST; He Y
    Acc Chem Res; 2014 Feb; 47(2):612-23. PubMed ID: 24397270
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Intracellular and extracellular targets as mechanisms of cancer therapy by nanomaterials in relation to their physicochemical properties.
    Andraos C; Gulumian M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Mar; 13(2):e1680. PubMed ID: 33111484
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mechanisms of Regulated Cell Death: Current Perspectives.
    Santagostino SF; Assenmacher CA; Tarrant JC; Adedeji AO; Radaelli E
    Vet Pathol; 2021 Jul; 58(4):596-623. PubMed ID: 34039100
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Two-dimensional cancer theranostic nanomaterials: Synthesis, surface functionalization and applications in photothermal therapy.
    Murugan C; Sharma V; Murugan RK; Malaimegu G; Sundaramurthy A
    J Control Release; 2019 Apr; 299():1-20. PubMed ID: 30771414
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Recent Advances in Polymeric Nanomedicines for Cancer Immunotherapy.
    Lee ES; Shin JM; Son S; Ko H; Um W; Song SH; Lee JA; Park JH
    Adv Healthc Mater; 2019 Feb; 8(4):e1801320. PubMed ID: 30666822
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Carbon nanostructures for orthopedic medical applications.
    Yang L; Zhang L; Webster TJ
    Nanomedicine (Lond); 2011 Sep; 6(7):1231-44. PubMed ID: 21929458
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Multidimensional (0D-3D) nanostructures for lung cancer biomarker analysis: Comprehensive assessment on current diagnostics.
    Ramanathan S; Gopinath SCB; Md Arshad MK; Poopalan P
    Biosens Bioelectron; 2019 Sep; 141():111434. PubMed ID: 31238281
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Perspectives and potential applications of nanomedicine in breast and prostate cancer.
    Liu Y; Solomon M; Achilefu S
    Med Res Rev; 2013 Jan; 33(1):3-32. PubMed ID: 23239045
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Glyco-nanomaterials: translating insights from the "sugar-code" to biomedical applications.
    El-Boubbou K; Huang X
    Curr Med Chem; 2011; 18(14):2060-78. PubMed ID: 21517769
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Glyconanoparticles: multifunctional nanomaterials for biomedical applications.
    García I; Marradi M; Penadés S
    Nanomedicine (Lond); 2010 Jul; 5(5):777-92. PubMed ID: 20662648
    [TBL] [Abstract][Full Text] [Related]  

  • 72. AFM Analysis Enables Differentiation between Apoptosis, Necroptosis, and Ferroptosis in Murine Cancer Cells.
    Van der Meeren L; Verduijn J; Krysko DV; Skirtach AG
    iScience; 2020 Dec; 23(12):101816. PubMed ID: 33299979
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Nanotechnology platforms and physiological challenges for cancer therapeutics.
    Kim KY
    Nanomedicine; 2007 Jun; 3(2):103-10. PubMed ID: 17442621
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Miconazole triggers various forms of cell death in human breast cancer MDA-MB-231 cells.
    Chengzhu WU; Gao M; Shen L; Bohan LI; Bai X; Gui J; Hongmei LI; Huo Q; Tao MA
    Pharmazie; 2019 May; 74(5):290-294. PubMed ID: 31109399
    [TBL] [Abstract][Full Text] [Related]  

  • 75. MicroRNAs in cancer cell death pathways: Apoptosis and necroptosis.
    Shirjang S; Mansoori B; Asghari S; Duijf PHG; Mohammadi A; Gjerstorff M; Baradaran B
    Free Radic Biol Med; 2019 Aug; 139():1-15. PubMed ID: 31102709
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nanotechnology and human health: risks and benefits.
    Cattaneo AG; Gornati R; Sabbioni E; Chiriva-Internati M; Cobos E; Jenkins MR; Bernardini G
    J Appl Toxicol; 2010 Nov; 30(8):730-44. PubMed ID: 21117037
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Shikonin-induced necroptosis is enhanced by the inhibition of autophagy in non-small cell lung cancer cells.
    Kim HJ; Hwang KE; Park DS; Oh SH; Jun HY; Yoon KH; Jeong ET; Kim HR; Kim YS
    J Transl Med; 2017 May; 15(1):123. PubMed ID: 28569199
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Nanomedicine as an innovative therapeutic strategy for pediatric lung diseases.
    Tian Y; Chen J; Zahtabi F; Keijzer R; Xing M
    Pediatr Pulmonol; 2013 Nov; 48(11):1098-111. PubMed ID: 23997035
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Organic Nanomaterials and Their Applications in the Treatment of Oral Diseases.
    Virlan MJ; Miricescu D; Radulescu R; Sabliov CM; Totan A; Calenic B; Greabu M
    Molecules; 2016 Feb; 21(2):. PubMed ID: 26867191
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Multifunctional magnetoplasmonic nanomaterials and their biomedical applications.
    Zhou H; Zou F; Koh K; Lee J
    J Biomed Nanotechnol; 2014 Oct; 10(10):2921-49. PubMed ID: 25992424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.